Domov › Non-Hodgkinov lymfóm › Illinois › Chicago
Klinické štúdie Non-Hodgkinov lymfóm v meste Chicago, IL
18 štúdií pre Non-Hodgkinov lymfóm hľadá účastníkov v zariadeniach v meste Chicago a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Prebieha náborFáza 2
- Cancer Treatment Centers of America-Chicago, Chicago
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Prebieha náborFáza 1
- The University of Chicago Medical Center (UCMC), Chicago
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
Prebieha náborFáza 2
- Research Site, Chicago
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Prebieha náborFáza 1/2
- Lurie Children's Hospital-Chicago, Chicago
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Prebieha náborFáza 1/2
- University of Chicago Medical Center, Chicago
A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
Prebieha náborFáza 1
- The David and Etta Jonas Center for Cellular Therapy, Chicago
Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
Prebieha náborObservačná štúdia
- Robert H Lurie Cancer Center, Chicago
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Prebieha náborFáza 3
- Northwestern, Chicago
- University of Chicago, Chicago
DALY II USA/ MB-CART2019.1 for DLBCL
Prebieha náborFáza 2
- Robert H Lurie Cancer Center, Chicago
Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
Prebieha náborFáza 1
- University of Illinois at Chicago, Chicago
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Prebieha náborObservačná štúdia
- Northwestern Memorial Hospital, Chicago
- Rush University Medical Center, Chicago
- University of Illinois at Chicago, Chicago
- a 2 ďalších
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
Prebieha náborFáza 1
- University of Chicago, Chicago
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Prebieha náborFáza 1/2
- Northwestern Memorial Hospital, Chicago
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Prebieha náborObservačná štúdia
- John H Stroger Jr Hospital of Cook County, Chicago
- Advocate Illinois Masonic Medical Center, Chicago
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
Prebieha náborFáza 4
- Northwestern University, Chicago
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
Prebieha náborFáza 4
- Northwestern University, Chicago
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
Prebieha náborFáza 1
- Northwestern Memorial Hospital, Chicago
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Prebieha náborObservačná štúdia
- Massive Bio SYNERGY-AI site, Chicago
Štúdie Non-Hodgkinov lymfóm v iných mestách
- New York City, NY31 štúdií
- Houston, TX31 štúdií
- Boston, MA26 štúdií
- Nashville, TN21 štúdií
- Philadelphia, PA20 štúdií
- Baldwin Park, CA19 štúdií
- Washington, DC18 štúdií
- Atlanta, GA18 štúdií
- Milwaukee, WI18 štúdií
- Columbus, OH18 štúdií
- Dallas, TX17 štúdií
- Seattle, WA16 štúdií
Iné štúdie v Chicago
- Nemalobunkový karcinóm pľúc61 štúdií
- Rakovina prsníka59 štúdií
- Rakovina (všetky typy)51 štúdií
- Metastatická rakovina45 štúdií
- Rakovina prostaty45 štúdií
- Rakovina pľúc41 štúdií
- Obézita41 štúdií
- Rakovina vaječníkov36 štúdií
- Kolorektálny karcinóm34 štúdií
- Cievna mozgová príhoda34 štúdií
- Srdcové zlyhanie31 štúdií
- Nadváha29 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.